Concepedia

Pharmacokinetic approach to the selection of dose schedules for medroxyprogesterone acetate in clinical oncology

V. Tamassia, Agatino Battaglia, Fabrizio Ganzina, Anna Maria Isetta, G. Sacchetti, F. Cavalli, Aron Goldhirsch, K. Brunner, Grisi Bernardo, G. Robustelli della Cuna

Cancer Chemotherapy and Pharmacology · 1982 · 33 citations · 13 references

DOI

Concepts

References

13

Serum Medroxyprogesterone Acetate (MPA) Concentrations and Ovarian Function Following Intramuscular Injection of Depo-MPA

A. Ortiz, M. Hiroi, Frank Z. Stanczyk et al. · The Journal of Clinical Endocrinology & Metabolism · 1977 · 190 citations

, , +16

Measurement of Medroxyprogesterone Acetate (Provera) by Radioimmunoassay<sup>1</sup>

James C. Cornette, K.T. Kirton, Gordon W. Duncan · The Journal of Clinical Endocrinology & Metabolism · 1971 · 111 citations

, , +17

Hormonoprophylaxis and hormonotherapy in the treatment of endometrial adenocarcinoma by means of medroxyprogesterone acetate

J Bonte, J.M. Decoster, P. Ide et al. · Gynecologic Oncology · 1978 · 69 citations

, , +10

A possible new approach to the treatment of metastatic breast cancer: massive doses of medroxyprogesterone acetate.

F Pannuti, Andrea Martoni, Lenaz Gr et al. · PubMed · 1978 · 67 citations

, , +17

Medroxyprogesterone acetate, estradiol, FSH and LH in peripheral blood after intramuscular administration of depo-provera® to women

Sten Jeppsson, Johansson E.D.B. · Contraception · 1976 · 67 citations

, , +11